2.A Case of Dermatomyositis Diagnosed at Postpartum.
Korean Journal of Obstetrics and Gynecology 2006;49(3):722-726
Dermatomyositis is identified by a characteristic rash accompanying or, more commonly, preceding muscle weakness. Only 14% of cases occurs during child-bearing years, and only a few cases of dermatomyositis associated to pregnancy complications have been reported. Therefore there is relatively little information concerning the maternal and fetal outcome. The clinical diagnosis of dermatomyositis is confirmed by three laboratory examinations: serum muscle enzyme concentrations, electromyography, and muscle biopsy. Some authors suggest that the outlook for the fetus is unfavorable when dermatomyositis is first diagnosed during pregnancy. Others consider that fetal prognosis parallels the activity of maternal disease. Various factors have been considered as triggers for development of dermatomyositis during pregnancy. There is no report of maternal-to-fetal transmission of disease. We have experienced a case of dermatomyositis diagnosed at postpartum and then received a prompt management of the patient so presented this case with a brief review of the literatures.
Autoimmune Diseases
;
Biopsy
;
Connective Tissue Diseases
;
Dermatomyositis*
;
Diagnosis
;
Electromyography
;
Exanthema
;
Fetus
;
Humans
;
Muscle Weakness
;
Postpartum Period*
;
Pregnancy
;
Pregnancy Complications
;
Prognosis
4.Etiology and clinical features of fever of unknown origin.
Ma JIN-LING ; Cao JIAN ; Wang YU-TANG ; Guo YAN-YAN ; Meng QING-YI
Acta Academiae Medicinae Sinicae 2011;33(1):83-87
OBJECTIVETo investigate the etiology and clinical features of fever of unknown origin (FUO).
METHODSThe clinical data including etiology, diagnostic approaches, and clinical features were retrospectively analyzed in 816 patients with FUO who were presented in our department from January 2000 to January 2009.
RESULTSOf these 816 FUO cases, 766 (93.9%) were confirmed to be with infective diseases(40.4%, n=330), connective tissue diseases (34.4%, n=281), malignant tumors (10.9%, n=89), other known diseases (8.1%, n=66), and unknown diseases (6.1%, n=50). The most common infective disease was tuberculosis (49.7%, 164/330), the most common connective tissue disease was adult-onset Stills disease (AOSD)(55.2%, 155/281), the most common malignant tumor was lymphoma(56.2%, 50/89), and the most common "other known disease" was Crohns disease(22.7%, 15/66). All lung cancer cases had obstructive pneumonia. Significantly more elderly patients suffered from infective diseases (49.4% vs.32.0%) and malignant tumor (15.6% vs. 6.4%) compared with the non-elderly (both P=0.0000), while the proportion of connective tissue diseases was significantly less than that of the non-elderly (17.9% vs. 50.1%, P=0.0000).
CONCLUSIONSMost FUO can be confirmed after careful examinations and analysis. The main cause of FUO is infective diseases, especially tuberculosis in the elderly. The connective tissue diseases and malignant tumors are also important causes.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Connective Tissue Diseases ; complications ; Female ; Fever of Unknown Origin ; diagnosis ; etiology ; Humans ; Male ; Middle Aged ; Neoplasms ; complications ; Retrospective Studies ; Tuberculosis ; complications ; Young Adult
5.Analysis of pregnancy outcomes, disease progression, and risk factors in patients with undifferentiated connective tissue disease.
Fang Ning YOU ; Liang LUO ; Xiang Jun LIU ; Xue Wu ZHANG ; Chun LI
Journal of Peking University(Health Sciences) 2023;55(6):1045-1052
OBJECTIVE:
To investigate the fetal and maternal outcomes, risk factors of disease progression and adverse pregnancy outcomes (APOs) in patients with undifferentiated connective tissue disease (UCTD).
METHODS:
This retrospective study described the outcomes of 106 pregnancies in patients with UCTD. The patients were divided into APOs group (n=53) and non-APOs group (n=53). The APOs were defined as miscarriage, premature birth, pre-eclampsia, premature rupture of membranes (PROM), intrauterine growth restriction (IUGR), postpartum hemorrhage (PPH), and stillbirth, small for gestational age infant (SGA), low birth weight infant (LBW) and birth defects. The differences in clinical manifestations, laboratory data and pregnancy outcomes between the two groups were compared. Logistic regression analysis was performed to analyze the risk factors for APOs and the progression of UCTD to definitive CTD.
RESULTS:
There were 99 (93.39%) live births, 4 (3.77%) stillbirths and 3 (2.83%) miscarriage, 20 (18.86%) preterm delivery, 6 (5.66%) SGA, 17 (16.03%) LBW, 11 (10.37%) pre-eclampsia, 7 (6.60%) cases IUGR, 19 (17.92%) cases PROM, 10 (9.43%) cases PPH. Compared with the patients without APOs, the patients with APOs had a higher positive rate of anti-SSA antibodies (73.58% vs. 54.71%, P=0.036), higher rate of leukopenia (15.09% vs. 3.77%, P=0.046), lower haemoglobin level [109.00 (99.50, 118.00) g/L vs. 124.00 (111.50, 132.00) g/L, P < 0.001].Multivariate Logistic regression analysis showed that leucopenia (OR=0.82, 95%CI: 0.688-0.994) was an independent risk factors for APOs in UCTD (P=0.042). Within a mean follow-up time of 5.00 (3.00, 7.00) years, the rate of disease progression to a definite CTD was 14.15%, including 8 (7.54%) Sjögren's syndrome, 4 (3.77%) systemic lupus erythematosus (SLE), 4 (3.77%) rheumatoid arthritis and 1 (0.94%) mixed connective tissue disease. Multivariate Cox proportional risk regression analysis showed that Raynaud phenomenon (HR=40.157, 95%CI: 3.172-508.326) was an independent risk factor for progression to SLE.
CONCLUSION
Leukopenia is an independent risk factor for the development of APOs in patients with UCTD. Raynaud's phenmon is a risk factor for the progression of SLE. Tight disease monitoring and regular follow-up are the key measures to prevent adverse pregnancy outcomes and predict disease progression in UCTD patients with pregnancy.
Pregnancy
;
Infant, Newborn
;
Female
;
Humans
;
Pregnancy Outcome
;
Retrospective Studies
;
Abortion, Spontaneous/etiology*
;
Undifferentiated Connective Tissue Diseases
;
Pre-Eclampsia/epidemiology*
;
Lupus Erythematosus, Systemic
;
Risk Factors
;
Leukopenia
;
Pregnancy Complications/epidemiology*
;
Disease Progression
;
Connective Tissue Diseases/epidemiology*
6.Nerve conduction studies in patients with dermatomyositis or polymyositis.
Yue WANG ; Li-ying CUI ; Lin CHEN ; Ming-sheng LIU ; Xin QI ; Ben-hong LI ; Hua DU
Chinese Medical Journal 2010;123(5):523-526
BACKGROUNDInvolvement of peripheral nerves in dermatomyositis (DM) and polymyositis (PM) is less well known. In the present study we retrospectively analyzed the clinical and electrophysiological records of hospital inpatients with a diagnosis of DM or PM to investigate the association of DM/PM and peripheral neuropathy.
METHODSThe data of inpatients diagnosed with DM or PM were collected in Peking Union Medical College Hospital, and 186 patients (118 patients with DM and 68 with PM) were retrospectively analyzed. Nerve conduction studies (NCSs) of the median nerve, ulnar nerve, posterior tibial nerve, and common peroneal nerve were examined simultaneously.
RESULTSThere were 71 (38.2%) patients with abnormal NCS findings, 37 (19.9%) with pure motor involvement (decreased compound muscle action potential, CMAP), and 34 (18.3%) with peripheral neuropathy. Of the 34 peripheral neuropathy patients, 14 (7.5%) had polyneuropathy, 1 (0.5%) had multiple mononeuropathy, 16 (8.6%) had carpal tunnel syndrome (CTS), 1 (0.5%) had trigeminal sensory neuropathy, 1 (0.5%) had ulnar sensory neuropathy, and 1 (0.5%) had brachial plexus involvement. The prevalence of malignant disease (3/34, 8.8%), other connective tissue diseases (CTDs) (7/34, 20.6%) and diabetes (6/34, 17.6%) was significantly greater in DM/PM patients with peripheral neuropathy (chi(2) = 15.855, P = 0.000) compared with DM/PM patients without involvement of peripheral nerves (5/115, 4.3% and 7/115, 6.1%, respectively).
CONCLUSIONSPeripheral neuropathy in DM/PM often suggests a complication with cancer, other CTDs, diabetes or CTS. From a practical point of view, NCS for DM/PM may help find the underlying disorders.
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Connective Tissue Diseases ; complications ; Dermatomyositis ; complications ; physiopathology ; Female ; Humans ; Male ; Middle Aged ; Neural Conduction ; Peripheral Nervous System Diseases ; etiology ; Polymyositis ; complications ; physiopathology ; Retrospective Studies
7.Short- and Long-term Outcomes in Patients with Connective Tissue Diseases Undergoing Percutaneous Coronary Intervention.
Li ZHOU ; Hui CHEN ; Wei-Ping LI ; Hong-Li GAO ; Dong-Bao LI ; Hui-Qiang ZHAO ; Dao-Kuo YAO ; Hong-Wei LI
Chinese Medical Journal 2016;129(7):804-808
BACKGROUNDCoronary artery disease (CAD) is a leading cause of morbidity and mortality in patients with connective tissue diseases (CTDs). Risk factors and clinical characteristics in these patients are not equivalent to those in traditional CAD patients. The objective of this study was to report short- and long-term clinical outcomes in a consecutive series of patients with CTD who underwent percutaneous coronary intervention (PCI) with stent implantation.
METHODSThe study group comprised 106 consecutive patients with CTD who underwent PCI in Beijing Friendship Hospital between January 2009 and June 2012. Medical records were analyzed retrospectively including clinical basic material, coronary angiogram data, and the incidence of major adverse cardiac events (MACEs) during the short- and long-term (median 3 years) follow-up.
RESULTSNinety-two of the patients (86.8%) had one or more traditional CAD risk factors. Multivessel disease was present in more than 2/3 of patients (73.6%). The left anterior descending coronary artery was the most commonly affected vessel (65.1%). Five bare-metal stents and 202 drug-eluting stents were implanted. After a median follow-up period of 36 months, thirteen patients (12.3%) died from cardiac causes, the rate of stent thrombosis was 9.4%, and the rate of target vessel revascularization (TVR) was 14.2%. Multivariate analysis revealed that hypertension (hazard ratio [HR] = 3.07, 95% confidence interval [CI]: 1.30-7.24, P = 0.041), anterior myocardial infarction (HR = 2.77, 95% CI: 1.06-7.03, P = 0.04), longer duration of steroid treatment (HR = 3.60, 95% CI: 1.43-9.08, P = 0.032), and C-reactive protein level >10 mg/L (HR = 3.98, 95% CI: 1.19-12.56, P = 0.036) were independent predictors of MACEs.
CONCLUSIONSPatients with CTD and CAD may have severe coronary lesions. PCI in these patients tends to result in an increased rate of stent thrombosis and TVR during long-term follow-up, which may be influenced by traditional and nontraditional risk factors.
Aged ; C-Reactive Protein ; analysis ; Connective Tissue Diseases ; complications ; Coronary Angiography ; Drug-Eluting Stents ; Female ; Humans ; Male ; Middle Aged ; Percutaneous Coronary Intervention ; Retrospective Studies ; Treatment Outcome
8.Clinical analysis of pulmonary arterial hypertension secondary to connective tissue disease in children.
Yan XING ; Hong-mei SONG ; Xiao-yan WU ; Yan-yan HE ; Min WEI
Chinese Journal of Pediatrics 2008;46(11):822-826
OBJECTIVETo study the epidemiology, clinical characteristics and prognosis of children with pulmonary arterial hypertension (PAH) secondary to connective tissue disease (CTD).
METHODSThe clinical record files of the pediatric inpatient with PAH in the population of CTD in the hospital treated between January 2000 and January 2007 were analyzed retrospectively.
RESULTS(1) In 299 patients with CTD and complete Doppler echocardiography files, 31 (31/299, 10.4%) patients (28 females and 3 males), aged from 7 to 18 years (average: 12.5 years), were found to have PAH, in whom, 5(62.5%)in 8 patients with overlapped CTD (OCTD), 2 (50.0%) in 4 patients with antiphospholipid syndrome (APS), 4(28.6%) in 14 patients with systematic vasculitis (SV), 3 (10.7%) in 28 patients with dermatomyositis (DM), 17(7.6%) in 223 systemic lupus erythematosus (SLE) had PAH. The CTD-associated PAH occurred in the 3rd week to 5th year after initial CTD manifestations (median onset: 1.5 years). (2) The onset of CTD-associated PAH was obscure and children with severe CTD-associated PAH presented with dyspnea (18/31, 58.1%) and heart failure (9/31, 29.0%). The children with Raynaud's phenomenon or positive anticardiophospholipid antibody (ACL) or positive lupus anticoagulant (LA) were prone to have more severe PAH. (3) Doppler echocardiography and pulmonary function test, especially the test of pulmonary diffusion function of CO (D(LCO)) were necessary to detect PAH early. (4) After treatment, the pulmonary arterial pressure in mild and moderate PAH cases could be normalized and in severe PAH cases could be decreased to mild or moderate levels. There was a lower PaO(2) level (P < 0.01), a higher pulmonary arterial systolic pressure (PASP) level (P < 0.05) in the cases of CTD-PAH who died as compared with the live patients.
CONCLUSIONSPAH is a common complication of CTDs, which occurs often 1.5 years after initial CTD manifestations. The early associated symptom is obscure and the severe cases manifest with dyspnea and heart failure. Those with Raynaud's phenomenon and positive ACL and LA are prone to develop more severe PAH. Early and regular Doppler echocardiography and pulmonary function test are necessary to detect PAH early. Severe CTD associated PAH in children could lead to poor outcome. PASP classification and PaO(2) level are important factors affecting prognosis.
Adolescent ; Child ; Connective Tissue Diseases ; complications ; diagnostic imaging ; physiopathology ; Echocardiography, Doppler ; Female ; Humans ; Hypertension, Pulmonary ; diagnostic imaging ; etiology ; Male ; Prognosis ; Respiratory Function Tests ; Retrospective Studies
9.Charlson comorbidity index as a predictor of periodontal disease in elderly participants
Jae Hong LEE ; Jung Kyu CHOI ; Seong Nyum JEONG ; Seong Ho CHOI
Journal of Periodontal & Implant Science 2018;48(2):92-102
PURPOSE: This study investigated the validity of the Charlson comorbidity index (CCI) as a predictor of periodontal disease (PD) over a 12-year period. METHODS: Nationwide representative samples of 149,785 adults aged ≥60 years with PD (International Classification of Disease, 10th revision [ICD-10], K052–K056) were derived from the National Health Insurance Service-Elderly Cohort during 2002–2013. The degree of comorbidity was measured using the CCI (grade 0–6), including 17 diseases weighted on the basis of their association with mortality, and data were analyzed using multivariate Cox proportional-hazards regression in order to investigate the associations of comorbid diseases (CDs) with PD. RESULTS: The multivariate Cox regression analysis with adjustment for sociodemographic factors (sex, age, household income, insurance status, residence area, and health status) and CDs (acute myocardial infarction, congestive heart failure, peripheral vascular disease, cerebral vascular accident, dementia, pulmonary disease, connective tissue disorders, peptic ulcer, liver disease, diabetes, diabetes complications, paraplegia, renal disease, cancer, metastatic cancer, severe liver disease, and human immunodeficiency virus [HIV]) showed that the CCI in elderly comorbid participants was significantly and positively correlated with the presence of PD (grade 1: hazard ratio [HR], 1.11; P < 0.001; grade ≥2: HR, 1.12, P < 0.001). CONCLUSIONS: We demonstrated that a higher CCI was a significant predictor of greater risk for PD in the South Korean elderly population.
Adult
;
Aged
;
Classification
;
Cohort Studies
;
Comorbidity
;
Connective Tissue
;
Dementia
;
Diabetes Complications
;
Family Characteristics
;
Heart Failure
;
HIV
;
Humans
;
Insurance Coverage
;
Liver Diseases
;
Lung Diseases
;
Mortality
;
Myocardial Infarction
;
National Health Programs
;
Paraplegia
;
Peptic Ulcer
;
Periodontal Diseases
;
Peripheral Vascular Diseases
;
Risk Factors
10.Immune and coagulation profiles in 3 adults with multisystem inflammatory syndrome.
Ruth Xian Lynn YAP ; Bernard Pui Lam LEUNG ; Hwee Siew HOWE ; Mung Ee LOH ; Barnaby Edward YOUNG ; Bingwen Eugene FAN ; Xin Rong LIM
Annals of the Academy of Medicine, Singapore 2023;52(2):80-87
INTRODUCTION:
There is a paucity of information on the cytokine, complement, endothelial activation, and coagulation profiles of multisystem inflammatory syndrome in adults (MIS-A), a rare but serious complication following recovery from SARS-CoV-2 infection. We aim to examine the immune biomarker and coagulation profiles in association with the clinical presentation and course of MIS-A.
METHOD:
The clinical features of MIS-A patients admitted to our tertiary hospital were documented. Their levels of interleukin (IL)-1β, IL-6, IL-10, IL-17, IL-18, interferon-α (IFN-α), IFN-γ, interferon gamma-induced protein 10 (IP-10), tumour necrosis factor (TNF)-α, monocyte chemoattractant protein (MCP)-1, complement activation product (complement 5a [C5a]), and endothelial biomarker intercellular adhesion molecule-1 (ICAM-1) levels were assayed. The haemostatic profile was assessed with standard coagulation testing and thromboelastography.
RESULTS:
Three male patients were diagnosed with MIS-A at our centre from January to June 2022 with a median age of 55 years. All had tested positive for SARS-CoV-2 12-62 days prior to MIS-A presentation, with gastrointestinal and cardiovascular systems as the most commonly involved. Levels of IL-6, IL-10, IL-18, IP-10 and MCP-1 were raised whereas IL-1β, IFN-α, IFN-γ, IL-17 and TNF-α remained normal. Markedly elevated levels of C-reactive protein (CRP), ferritin and ICAM-1 were present in all. C5a was elevated in 2 patients. A hypercoagulable state was demonstrated by raised levels of D-dimer, factor VIII, von Willebrand factor antigen, and ristocetin cofactor with corresponding raised parameters in thromboelastography in the 2 patients who had their coagulation profile assessed.
CONCLUSION
MIS-A patients demonstrate activation of pro-inflammatory cytokines, endotheliopathy, complement hyperactivation and hypercoagulability.
Humans
;
Adult
;
Male
;
Middle Aged
;
COVID-19/complications*
;
Interleukin-10
;
Interleukin-18
;
Intercellular Adhesion Molecule-1
;
Interleukin-17
;
Chemokine CXCL10
;
Interleukin-6
;
SARS-CoV-2
;
Connective Tissue Diseases
;
Hemostatics